790 Memorial Drive
Suite 200B
Magen BioSciences is using its co-founder's new research findings on the signaling pathways underlying melanin production to develop drugs for disfiguring dermatological pigmentation disorders.
790 Memorial Drive
Suite 200B
Sun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business.
The Belgian drugmaker is boosting its biologics capacity over the pond.
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.